doi: 10.2147/OTT.S432665.
eCollection 2023.
LncRNA XIST Depletion Prevents Cancer Progression in Invasive Pituitary Neuroendocrine Tumor by Inhibiting bFGF via Upregulation of microRNA-424-5p [Retraction]
- PMID: 37546175
- PMCID: PMC10402883
- DOI: 10.2147/OTT.S432665
Item in Clipboard
LncRNA XIST Depletion Prevents Cancer Progression in Invasive Pituitary Neuroendocrine Tumor by Inhibiting bFGF via Upregulation of microRNA-424-5p [Retraction]
Onco Targets Ther.
.
Abstract
[This retracts the article DOI: 10.2147/OTT.S208329.].
© 2023 Dove Medical Press.
Retraction of
-
LncRNA XIST depletion prevents cancer progression in invasive pituitary neuroendocrine tumor by inhibiting bFGF via upregulation of microRNA-424-5p.Onco Targets Ther. 2019 Sep 2;12:7095-7109. doi: 10.2147/OTT.S208329. eCollection 2019. Onco Targets Ther. 2019. Retraction in: Onco Targets Ther. 2023 Jul 31;16:649-650. doi: 10.2147/OTT.S432665. PMID: 31564894 Free PMC article. Retracted.
Similar articles
-
LncRNA XIST depletion prevents cancer progression in invasive pituitary neuroendocrine tumor by inhibiting bFGF via upregulation of microRNA-424-5p.Onco Targets Ther. 2019 Sep 2;12:7095-7109. doi: 10.2147/OTT.S208329. eCollection 2019. Onco Targets Ther. 2019. Retraction in: Onco Targets Ther. 2023 Jul 31;16:649-650. doi: 10.2147/OTT.S432665. PMID: 31564894 Free PMC article. Retracted.
-
LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):9889-9898. doi: 10.26355/eurrev_202010_23199. Eur Rev Med Pharmacol Sci. 2020. PMID: 33090392
-
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction].Onco Targets Ther. 2021 Mar 30;14:2235. doi: 10.2147/OTT.S312745. eCollection 2021. Onco Targets Ther. 2021. PMID: 33833521 Free PMC article.
-
LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].Onco Targets Ther. 2022 Jun 15;15:681-682. doi: 10.2147/OTT.S378352. eCollection 2022. Onco Targets Ther. 2022. PMID: 35733651 Free PMC article.
-
LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation [Retraction].Onco Targets Ther. 2021 Sep 30;14:4939-4940. doi: 10.2147/OTT.S341523. eCollection 2021. Onco Targets Ther. 2021. PMID: 34621126 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
